GET MORE AI-GENERATED SIGNALS: November 06, 2024, 16:36 pm ET, BY Thomas Y.- Contributor| Editor: Thomas H. Kee Jr. ( Follow ...

ARLINGTON, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of ...

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on Kala Pharmaceuticals (KALA – Research Report) today and set a price target of $15.00. Yi Chen has given his Buy rating due to a combination ...

Kala Pharmaceuticals ( (KALA)) has released its Q3 earnings. Here is a breakdown of the information Kala Pharmaceuticals presented to its investors. Kala Pharmaceuticals, operating under the name ...

KALA BIO, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...